Genomic surveillance of invasive Neisseria meningitidis isolates circulating in Paraguay, 2009–2021
- 17 June 2025
- journal article
- research article
- Published by Springer Nature in International Microbiology
- p. 1-10
Abstract
Introduction Invasive meningococcal disease (IMD) remains a significant public health concern and one of the leading causes of morbidity and mortality worldwide. In Paraguay, IMD continues to pose a serious health challenge. Methodology A retrospective, descriptive, cross-sectional observational study was conducted. Whole-genome sequencing was employed to perform multilocus sequence sequence typing (MLST), vaccine antigens characterization, and antimicrobial resistance gene profiling of Neisseria meningitidis isolates obtained from children and adults with IMD, as part of the Bacterial Meningitis Surveillance Program in Paraguay during 2009–2021. Results Eight clonal complexes were identified, with cc103 being the most frequent, followed by cc11, cc35, cc167, cc41/44, cc865, cc32, and cc60. Regarding vaccine antigens, the fHbp variant A05 peptide targeted by MenB-FHbp was absent, whereas the B01 variant was detected in 3 out of 70 isolates (4.3%). For the 4CMenB vaccine components, peptide 1 of fHbp (subfamily B/variant 1), NHBA peptide 2, and NadA peptide 8 were absent, while PorA P1.7–2,4 was found in one isolate (1.4%). Mutated penA alleles were present in 73.7% of the isolates. Major peptides (PorA, PorB, FetA, NHBA, fHbp) were correlated with clonal complexes and serogroups. Conclusion This is the first genomic study of Neisseria meningitidis conducted in Paraguay, enabling a novel understanding of the genetic characteristics of invasive isolates. The generation of genomic data is essential for monitoring the spread of circulating lineages or clones that may alter their antigenic profiles to evade host immune responses.Keywords
This publication has 44 references indexed in Scilit:
- Meningococcal B Immunisation in Adults and Potential Broader Immunisation Strategies: A Narrative ReviewInfectious Diseases and Therapy, 2023
- Vaccines against Neisseria meningitidis serogroup B strains – What does genomics reveal on the Portuguese strain’s coverageVaccine, 2022
- The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccinationJournal of Infection, 2020
- Population structure of invasive Neisseria meningitidis in the United States, 2011–15Journal of Infection, 2018
- The bivalent factor H binding protein meningococcal serogroup B vaccine elicits bactericidal antibodies against representative non-serogroup B meningococciVaccine, 2018
- Dissemination of the ST-103 clonal complex serogroup C meningococci in Salvador, BrazilMicrobes and Infection, 2018
- Bivalent rLP2086 Vaccine (Trumenba®): A Review in Active Immunization Against Invasive Meningococcal Group B Disease in Individuals Aged 10–25 YearsBioDrugs, 2015
- The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: Immunological, functional and structural characterization of the antigensVaccine, 2012
- Neisseria meningitidis: Biology, Microbiology, and Epidemiology2011
- High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11 clone in Southern BrazilJournal of Infection, 2008